Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Ray Tarke who wrote (72)	3/7/1998 4:09:00 PM
From: Jeffrey L. Henken	Respond to of 2887

Tackling the competition: Tonights topic is how well does the Ahn Thrombectomy Catheter measure up to the competition? americanbiomed.com Extremely well indeed from what I read and hear. So who is the competition? How about Baxter Healthcare a huge multinational medical company which first developed the ballon catheter in the early 70's: baxter.com Baxter is a leading developer and manufacturer of catheters and instruments used in vascular surgery. The company is focusing on products and technologies to facilitate minimally invasive vascular procedures, including endovascular grafts, which may eliminate the need for open surgery in the repair of diseased blood vessels. I really think the Ahn Catheter has numerous advantages over Baxter's models. Wouldn't you agree Ray? Regards, Jeff